Stay updated on Rituximab in Eosinophilic Granulomatosis Clinical Trial
Sign up to get notified when there's something new on the Rituximab in Eosinophilic Granulomatosis Clinical Trial page.

Latest updates to the Rituximab in Eosinophilic Granulomatosis Clinical Trial page
- ChecktodayChange DetectedThe page's revision label was updated from v3.5.4 to v3.5.5, signaling a minor update to the study record page.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedThe page’s revision label changed from v3.5.3 to v3.5.4, signaling a minor update to the page. There is no evident modification to the study details, eligibility criteria, or results in the provided context.SummaryDifference0.1%

- Check36 days agoChange DetectedRevision label updated from v3.5.2 to v3.5.3 on the page. This reflects a minor deployment or content refresh to the study details page.SummaryDifference0.1%

- Check50 days agoChange DetectedRevision: v3.5.2 is now displayed, replacing the previous v3.5.0.SummaryDifference0.1%

- Check72 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check79 days agoChange DetectedThe study record now shows Completed status, the primary completion date, enrollment, and a new 2025 publication summarizing the results.SummaryDifference0.1%

Stay in the know with updates to Rituximab in Eosinophilic Granulomatosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rituximab in Eosinophilic Granulomatosis Clinical Trial page.